Parmax Pharma informs about revised standalone financial results

29 Mar 2017 Evaluate

Parmax Pharma has informed about Revised Standalone Financial Results for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

32.45 -2.59 (-7.39%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×